A new study published in the journal of BMC Nephrology showed that in patients receiving peritoneal dialysis (PD), the ...

THE Benefits Committee (BenCom) of the Philippine Health Insurance Corporation (PhilHealth) Board of Directors endorsed on Friday to the board en banc better benefit packages for heart attacks, 10 ...

The Philippine Health Insurance Corporation (PhilHealth) endorsed five 'better benefit packages' for heart attacks, rare ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Pharmanovia partners with Lindis Biotech to commercialise catmaxomab to treat rare condition, malignant ascites: Basildon, UK Thursday, November 21, 2024, 17:00 Hrs [IST] Pharmano ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...

Malignant ascites is an abnormal accumulation of fluid in the peritoneal cavity that commonly arises from ... evidence-based treatment guidelines or specific management recommendations for MA exist ...

Malignant ascites is an abnormal accumulation of fluid in the peritoneal cavity that commonly arises from ... evidence-based treatment guidelines or specific management recommendations for MA exist ...

If approved, Korjuny would become the only drug approved for the specific and cancer-directed treatment of malignant ascites, an abnormal accumulation of fluid in the peritoneal cavity ... in ...

aDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Mass General Brigham ... of HIPEC appears to be primarily driven by extending the peritoneal ...

Johnson & Johnson has been threatened with legal action in the UK over claims that its talcum powder products caused cancer.

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...